Bilateral intravitreal injection of antivascular endothelial growth factor therapy

Retina

Volumn 31, Issue 1, 2011, Pages 31-35

  Mahajan, Vinit B ^a,b   Elkins, Kori A ^a   Russell, Stephen R ^a   Boldt, H Culver ^a   Gehrs, Karen M ^a   Weingeist, Thomas A ^a   Stone, Edwin M ^a,c   Abràmoff, Michael D ^a,d   Liu, Dawei ^e   Folk, James C ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b Omics Laboratory   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

age related macular degeneration; anti VEGF

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB; VASCULOTROPIN ANTIBODY;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; ENDOPHTHALMITIS; FEMALE; HEART INFARCTION; HUMAN; MALE; PATIENT PREFERENCE; RETINA MACULA AGE RELATED DEGENERATION;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CASE-CONTROL STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INJECTIONS, INTRAOCULAR; MACULAR DEGENERATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT PREFERENCE; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 78651363717     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181ed8c80     Document Type: Article

References (11)

1. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431.
2. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-1444.
3. Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Arch Ophthalmol 1994; 112:500-509.
4. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Arch Ophthalmol 1993;111:1200-1209.
5. Boyer DS, Heier JS, Brown DM, Francom SF, Ianchulev T, Rubio RG. A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration. Ophthalmology 2009;116:1731-1739.
6. A Study of Ranibizumab Administered Monthly or on an As- Needed Basis in Patients With Subfoveal Neovascular Age- Related Macular Degeneration (HARBOR). February 7, 2010. Available at: Http://clinicaltrials.gov/ct2/show/NCT00891735. Accessed March 29, 2010.
7. Bakri SJ, Risco M, Edwards AO, Pulido JS. Bilateral simultaneous intravitreal injections in the office setting. Am J Ophthalmol 2009;148:66-69.
8. Lima LH, Zweifel SA, Engelbert M, et al. Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapy. Retina 2009;29:1213-1217.
9. Galler KE, Folk JC, Russell SR, et al. Patient Preference and Safety of Bilateral Intravitreal Injection of Anti-VEGF Therapy. Invest Ophthalmol Vis Sci 2009;50:E-Abstract 247. Available at: Http://abstracts.iovs.org//cgi/content/ abstract/50/5/247.
10. Likert R. Technique for the measurement of attitudes. Arch Psychol 1932;140:1-55.
11. Reicin AS, Shapiro D, Sperling RS, Barr E, Yu Q. Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen, diclofenac, and nabumetone). Am J Cardiol 2002;89:204-209.